APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Spatial Transcriptomics Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Spatial Transcriptomics Platform Market Outlook and Growth Opportunities 2026

Report ID 174547220412 August 2026199 pages

Choose your research edition.

Industry ResearchSpatial Transcriptomics Platform Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Spatial Transcriptomics Platform Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Spatial Transcriptomics Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spatial Transcriptomics Platform Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Spatial Transcriptomics Platform Market Analysis and Forecast 2026-2032178 pages · $4,950 USD

Market perspective

The global Spatial Transcriptomics Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Spatial Transcriptomics Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Spatial Transcriptomics Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spatial Transcriptomics Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Spatial Transcriptomics Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Spatial Transcriptomics Platform market include STOmics, Curio Bioscience, Resolve Biosciences, Bio-Techne, Miltenyi Biotec, SeekGene, BMKMANU, CapitalBio Technology and Dynamic Biosystems, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Spatial Transcriptomics Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Spatial Transcriptomics Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Spatial Transcriptomics Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Spatial Transcriptomics Platform market.

Spatial Transcriptomics Platform Segment by Company

STOmics

Curio Bioscience

Resolve Biosciences

Bio-Techne

Miltenyi Biotec

SeekGene

BMKMANU

CapitalBio Technology

Dynamic Biosystems

M20 Genomics

Singleron Biotechnologies

AtlasXomics

10x Genomics

Bruker

Vizgen

Spatial Transcriptomics Platform Segment by Type

Sequencing-Based Spatial Barcoding Platforms

Imaging-Based in Situ Hybridization Platforms

In Situ Sequencing Platforms

Region-of-Interest Digital Profiling Platforms

Spatial Single-Nucleus Sequencing Platforms

Other or Hybrid Platforms

Spatial Transcriptomics Platform Segment by Application

Oncology Research

Neuroscience Research

Developmental and Regenerative Biology

Immunology and Infectious Disease

Organ Physiology and Metabolic Disease

Other Life Science Research

Spatial Transcriptomics Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Spatial Transcriptomics Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Spatial Transcriptomics Platform key companies, revenue, market share, and recent developments.

3. To split the Spatial Transcriptomics Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Spatial Transcriptomics Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Spatial Transcriptomics Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Spatial Transcriptomics Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Transcriptomics Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spatial Transcriptomics Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Transcriptomics Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spatial Transcriptomics Platform industry.

Chapter 3: Detailed analysis of Spatial Transcriptomics Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Spatial Transcriptomics Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Spatial Transcriptomics Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Spatial Transcriptomics Platform Industry Trends Table 2. Spatial Transcriptomics Platform Industry Drivers Table 3. Spatial Transcriptomics Platform Industry Opportunities and Challenges Table 4. Spatial Transcriptomics Platform Industry Restraints Table 5. Global Spatial Transcriptomics Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Spatial Transcriptomics Platform Revenue Share by Company (2021-2026) Table 7. Global Spatial Transcriptomics Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Spatial Transcriptomics Platform Key Company Manufacturing Base & Headquarters Table 9. Global Spatial Transcriptomics Platform Company, Product Type & Application Table 10. Global Spatial Transcriptomics Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Spatial Transcriptomics Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Sequencing-Based Spatial Barcoding Platforms Table 15. Significant Companies of Imaging-Based in Situ Hybridization Platforms Table 16. Significant Companies of In Situ Sequencing Platforms Table 17. Significant Companies of Region-of-Interest Digital Profiling Platforms Table 18. Significant Companies of Spatial Single-Nucleus Sequencing Platforms Table 19. Significant Companies of Other or Hybrid Platforms Table 20. Global Spatial Transcriptomics Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Spatial Transcriptomics Platform Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Spatial Transcriptomics Platform Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Spatial Transcriptomics Platform Sales Value Share by Type (2021-2026) Table 24. Global Spatial Transcriptomics Platform Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Oncology Research Table 26. Significant Companies of Neuroscience Research Table 27. Significant Companies of Developmental and Regenerative Biology Table 28. Significant Companies of Immunology and Infectious Disease Table 29. Significant Companies of Organ Physiology and Metabolic Disease Table 30. Significant Companies of Other Life Science Research Table 31. Global Spatial Transcriptomics Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Spatial Transcriptomics Platform Sales Value by Application (2021-2026) & (US$ Million) Table 33. Global Spatial Transcriptomics Platform Sales Value by Application (2027-2032) & (US$ Million) Table 34. Global Spatial Transcriptomics Platform Sales Value Share by Application (2021-2026) Table 35. Global Spatial Transcriptomics Platform Sales Value Share by Application (2027-2032) Table 36. Global Spatial Transcriptomics Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Spatial Transcriptomics Platform Sales Value by Region (2021-2026) & (US$ Million) Table 38. Global Spatial Transcriptomics Platform Sales Value Share by Region (2021-2026) Table 39. Global Spatial Transcriptomics Platform Sales Value by Region (2027-2032) & (US$ Million) Table 40. Global Spatial Transcriptomics Platform Sales Value Share by Region (2027-2032) Table 41. Global Spatial Transcriptomics Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Spatial Transcriptomics Platform Sales Value by Country (2021-2026) & (US$ Million) Table 43. Global Spatial Transcriptomics Platform Sales Value Market Share by Country (2021-2026) Table 44. Global Spatial Transcriptomics Platform Sales Value by Country (2027-2032) & (US$ Million) Table 45. Global Spatial Transcriptomics Platform Sales Value Market Share by Country (2027-2032) Table 46. STOmics Company Information Table 47. STOmics Business Overview Table 48. STOmics Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. STOmics Spatial Transcriptomics Platform Product Portfolio Table 50. STOmics Recent Development Table 51. Curio Bioscience Company Information Table 52. Curio Bioscience Business Overview Table 53. Curio Bioscience Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Curio Bioscience Spatial Transcriptomics Platform Product Portfolio Table 55. Curio Bioscience Recent Development Table 56. Resolve Biosciences Company Information Table 57. Resolve Biosciences Business Overview Table 58. Resolve Biosciences Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. Resolve Biosciences Spatial Transcriptomics Platform Product Portfolio Table 60. Resolve Biosciences Recent Development Table 61. Bio-Techne Company Information Table 62. Bio-Techne Business Overview Table 63. Bio-Techne Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. Bio-Techne Spatial Transcriptomics Platform Product Portfolio Table 65. Bio-Techne Recent Development Table 66. Miltenyi Biotec Company Information Table 67. Miltenyi Biotec Business Overview Table 68. Miltenyi Biotec Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Miltenyi Biotec Spatial Transcriptomics Platform Product Portfolio Table 70. Miltenyi Biotec Recent Development Table 71. SeekGene Company Information Table 72. SeekGene Business Overview Table 73. SeekGene Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. SeekGene Spatial Transcriptomics Platform Product Portfolio Table 75. SeekGene Recent Development Table 76. BMKMANU Company Information Table 77. BMKMANU Business Overview Table 78. BMKMANU Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. BMKMANU Spatial Transcriptomics Platform Product Portfolio Table 80. BMKMANU Recent Development Table 81. CapitalBio Technology Company Information Table 82. CapitalBio Technology Business Overview Table 83. CapitalBio Technology Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. CapitalBio Technology Spatial Transcriptomics Platform Product Portfolio Table 85. CapitalBio Technology Recent Development Table 86. Dynamic Biosystems Company Information Table 87. Dynamic Biosystems Business Overview Table 88. Dynamic Biosystems Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Dynamic Biosystems Spatial Transcriptomics Platform Product Portfolio Table 90. Dynamic Biosystems Recent Development Table 91. M20 Genomics Company Information Table 92. M20 Genomics Business Overview Table 93. M20 Genomics Spatial Transcriptomics Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. M20 Genomics Spatial Transcriptomics Platform Product Portfolio Table 95. M20 Genomics Recent Development Table 96. Singleron Biotechnologies Company Information Table 97. Singleron Biotechnologies Business Overview Table 98. Singleron Biotechnologies Spatial Transcriptomics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Singleron Biotechnologies Spatial Transcriptomics Platform Product Portfolio Table 100. Singleron Biotechnologies Recent Development Table 101. AtlasXomics Company Information Table 102. AtlasXomics Business Overview Table 103. AtlasXomics Spatial Transcriptomics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. AtlasXomics Spatial Transcriptomics Platform Product Portfolio Table 105. AtlasXomics Recent Development Table 106. 10x Genomics Company Information Table 107. 10x Genomics Business Overview Table 108. 10x Genomics Spatial Transcriptomics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. 10x Genomics Spatial Transcriptomics Platform Product Portfolio Table 110. 10x Genomics Recent Development Table 111. Bruker Company Information Table 112. Bruker Business Overview Table 113. Bruker Spatial Transcriptomics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Bruker Spatial Transcriptomics Platform Product Portfolio Table 115. Bruker Recent Development Table 116. Vizgen Company Information Table 117. Vizgen Business Overview Table 118. Vizgen Spatial Transcriptomics Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Vizgen Spatial Transcriptomics Platform Product Portfolio Table 120. Vizgen Recent Development Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Spatial Transcriptomics Platform Product Image Figure 2. Global Spatial Transcriptomics Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spatial Transcriptomics Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Spatial Transcriptomics Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Sequencing-Based Spatial Barcoding Platforms Image Figure 8. Imaging-Based in Situ Hybridization Platforms Image Figure 9. In Situ Sequencing Platforms Image Figure 10. Region-of-Interest Digital Profiling Platforms Image Figure 11. Spatial Single-Nucleus Sequencing Platforms Image Figure 12. Other or Hybrid Platforms Image Figure 13. Global Spatial Transcriptomics Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Spatial Transcriptomics Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Spatial Transcriptomics Platform Sales Value Share by Type (2021-2032) Figure 16. Oncology Research Image Figure 17. Neuroscience Research Image Figure 18. Developmental and Regenerative Biology Image Figure 19. Immunology and Infectious Disease Image Figure 20. Organ Physiology and Metabolic Disease Image Figure 21. Other Life Science Research Image Figure 22. Global Spatial Transcriptomics Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Spatial Transcriptomics Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Spatial Transcriptomics Platform Sales Value Share by Application (2021-2032) Figure 25. Global Spatial Transcriptomics Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 26. Global Spatial Transcriptomics Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 27. North America Spatial Transcriptomics Platform Sales Value (2021-2032) & (US$ Million) Figure 28. North America Spatial Transcriptomics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Europe Spatial Transcriptomics Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Europe Spatial Transcriptomics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Asia-Pacific Spatial Transcriptomics Platform Sales Value (2021-2032) & (US$ Million) Figure 32. Asia-Pacific Spatial Transcriptomics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 33. South America Spatial Transcriptomics Platform Sales Value (2021-2032) & (US$ Million) Figure 34. South America Spatial Transcriptomics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Middle East & Africa Spatial Transcriptomics Platform Sales Value (2021-2032) & (US$ Million) Figure 36. Middle East & Africa Spatial Transcriptomics Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 37. USA Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. USA Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. USA Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Canada Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Canada Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Canada Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Mexico Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Mexico Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Mexico Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Germany Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Germany Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Germany Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. France Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. France Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. France Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. U.K. Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. U.K. Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. U.K. Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Italy Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Italy Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Italy Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Spain Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Spain Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Spain Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Russia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Russia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Russia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Netherlands Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Netherlands Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Netherlands Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Nordic Countries Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Nordic Countries Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Nordic Countries Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. China Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. China Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. China Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. Japan Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. Japan Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. Japan Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. South Korea Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. South Korea Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. South Korea Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. India Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. India Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. India Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Australia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Australia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Australia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Southeast Asia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Southeast Asia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Southeast Asia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Brazil Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Brazil Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Brazil Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Argentina Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Argentina Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Argentina Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Chile Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Chile Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Chile Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Colombia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Colombia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Colombia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Peru Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Peru Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Peru Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Saudi Arabia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Israel Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Israel Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Israel Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. UAE Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. UAE Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. UAE Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Turkey Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Turkey Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Turkey Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Iran Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Iran Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Iran Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Egypt Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Egypt Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Egypt Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Years Considered Figure 122. Research Process Figure 123. Key Executives Interviewed

Scope & coverage.

Types
  • Sequencing-Based Spatial Barcoding Platforms
  • Imaging-Based in Situ Hybridization Platforms
  • In Situ Sequencing Platforms
  • Region-of-Interest Digital Profiling Platforms
  • Spatial Single-Nucleus Sequencing Platforms
  • Other or Hybrid Platforms
Applications
  • Oncology Research
  • Neuroscience Research
  • Developmental and Regenerative Biology
  • Immunology and Infectious Disease
  • Organ Physiology and Metabolic Disease
  • Other Life Science Research
Companies covered
  • STOmics
  • Curio Bioscience
  • Resolve Biosciences
  • Bio-Techne
  • Miltenyi Biotec
  • SeekGene
  • BMKMANU
  • CapitalBio Technology
  • Dynamic Biosystems
  • M20 Genomics
  • Singleron Biotechnologies
  • AtlasXomics
  • 10x Genomics
  • Bruker
  • Vizgen

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Spatial Transcriptomics Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Spatial Transcriptomics Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Spatial Transcriptomics Platform Market Dynamics
  1. 2.1 Spatial Transcriptomics Platform Industry Trends
  2. 2.2 Spatial Transcriptomics Platform Industry Drivers
  3. 2.3 Spatial Transcriptomics Platform Industry Opportunities and Challenges
  4. 2.4 Spatial Transcriptomics Platform Industry Restraints
3 Spatial Transcriptomics Platform Market by Company
  1. 3.1 Global Spatial Transcriptomics Platform Company Revenue Ranking in 2025
  2. 3.2 Global Spatial Transcriptomics Platform Revenue by Company (2021-2026)
  3. 3.3 Global Spatial Transcriptomics Platform Company Ranking (2024-2026)
  4. 3.4 Global Spatial Transcriptomics Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Spatial Transcriptomics Platform Company Product Type and Application
  6. 3.6 Global Spatial Transcriptomics Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Spatial Transcriptomics Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Spatial Transcriptomics Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Spatial Transcriptomics Platform Market by Type
  1. 4.1 Spatial Transcriptomics Platform Type Introduction
  2. 4.1.1 Sequencing-Based Spatial Barcoding Platforms
  3. 4.1.2 Imaging-Based in Situ Hybridization Platforms
  4. 4.1.3 In Situ Sequencing Platforms
  5. 4.1.4 Region-of-Interest Digital Profiling Platforms
  6. 4.1.5 Spatial Single-Nucleus Sequencing Platforms
  7. 4.1.6 Other or Hybrid Platforms
  8. 4.2 Global Spatial Transcriptomics Platform Sales Value by Type
  9. 4.2.1 Global Spatial Transcriptomics Platform Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Spatial Transcriptomics Platform Sales Value by Type (2021-2032)
  11. 4.2.3 Global Spatial Transcriptomics Platform Sales Value Share by Type (2021-2032)
5 Spatial Transcriptomics Platform Market by Application
  1. 5.1 Spatial Transcriptomics Platform Application Introduction
  2. 5.1.1 Oncology Research
  3. 5.1.2 Neuroscience Research
  4. 5.1.3 Developmental and Regenerative Biology
  5. 5.1.4 Immunology and Infectious Disease
  6. 5.1.5 Organ Physiology and Metabolic Disease
  7. 5.1.6 Other Life Science Research
  8. 5.2 Global Spatial Transcriptomics Platform Sales Value by Application
  9. 5.2.1 Global Spatial Transcriptomics Platform Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Spatial Transcriptomics Platform Sales Value by Application (2021-2032)
  11. 5.2.3 Global Spatial Transcriptomics Platform Sales Value Share by Application (2021-2032)
6 Spatial Transcriptomics Platform Regional Value Analysis
  1. 6.1 Global Spatial Transcriptomics Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Spatial Transcriptomics Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Spatial Transcriptomics Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Spatial Transcriptomics Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Spatial Transcriptomics Platform Sales Value (2021-2032)
  7. 6.3.2 North America Spatial Transcriptomics Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Spatial Transcriptomics Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Spatial Transcriptomics Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Spatial Transcriptomics Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Spatial Transcriptomics Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Spatial Transcriptomics Platform Sales Value (2021-2032)
  16. 6.6.2 South America Spatial Transcriptomics Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Spatial Transcriptomics Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Spatial Transcriptomics Platform Sales Value Share by Country, 2025 VS 2032
7 Spatial Transcriptomics Platform Country-level Value Analysis
  1. 7.1 Global Spatial Transcriptomics Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Spatial Transcriptomics Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Spatial Transcriptomics Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Spatial Transcriptomics Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Spatial Transcriptomics Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Spatial Transcriptomics Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Spatial Transcriptomics Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 STOmics
  2. 8.1.1 STOmics Company Information
  3. 8.1.2 STOmics Business Overview
  4. 8.1.3 STOmics Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 STOmics Spatial Transcriptomics Platform Product Portfolio
  6. 8.1.5 STOmics Recent Developments
  7. 8.2 Curio Bioscience
  8. 8.2.1 Curio Bioscience Company Information
  9. 8.2.2 Curio Bioscience Business Overview
  10. 8.2.3 Curio Bioscience Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Curio Bioscience Spatial Transcriptomics Platform Product Portfolio
  12. 8.2.5 Curio Bioscience Recent Developments
  13. 8.3 Resolve Biosciences
  14. 8.3.1 Resolve Biosciences Company Information
  15. 8.3.2 Resolve Biosciences Business Overview
  16. 8.3.3 Resolve Biosciences Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Resolve Biosciences Spatial Transcriptomics Platform Product Portfolio
  18. 8.3.5 Resolve Biosciences Recent Developments
  19. 8.4 Bio-Techne
  20. 8.4.1 Bio-Techne Company Information
  21. 8.4.2 Bio-Techne Business Overview
  22. 8.4.3 Bio-Techne Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bio-Techne Spatial Transcriptomics Platform Product Portfolio
  24. 8.4.5 Bio-Techne Recent Developments
  25. 8.5 Miltenyi Biotec
  26. 8.5.1 Miltenyi Biotec Company Information
  27. 8.5.2 Miltenyi Biotec Business Overview
  28. 8.5.3 Miltenyi Biotec Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Miltenyi Biotec Spatial Transcriptomics Platform Product Portfolio
  30. 8.5.5 Miltenyi Biotec Recent Developments
  31. 8.6 SeekGene
  32. 8.6.1 SeekGene Company Information
  33. 8.6.2 SeekGene Business Overview
  34. 8.6.3 SeekGene Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 SeekGene Spatial Transcriptomics Platform Product Portfolio
  36. 8.6.5 SeekGene Recent Developments
  37. 8.7 BMKMANU
  38. 8.7.1 BMKMANU Company Information
  39. 8.7.2 BMKMANU Business Overview
  40. 8.7.3 BMKMANU Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BMKMANU Spatial Transcriptomics Platform Product Portfolio
  42. 8.7.5 BMKMANU Recent Developments
  43. 8.8 CapitalBio Technology
  44. 8.8.1 CapitalBio Technology Company Information
  45. 8.8.2 CapitalBio Technology Business Overview
  46. 8.8.3 CapitalBio Technology Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 CapitalBio Technology Spatial Transcriptomics Platform Product Portfolio
  48. 8.8.5 CapitalBio Technology Recent Developments
  49. 8.9 Dynamic Biosystems
  50. 8.9.1 Dynamic Biosystems Company Information
  51. 8.9.2 Dynamic Biosystems Business Overview
  52. 8.9.3 Dynamic Biosystems Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Dynamic Biosystems Spatial Transcriptomics Platform Product Portfolio
  54. 8.9.5 Dynamic Biosystems Recent Developments
  55. 8.10 M20 Genomics
  56. 8.10.1 M20 Genomics Company Information
  57. 8.10.2 M20 Genomics Business Overview
  58. 8.10.3 M20 Genomics Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 M20 Genomics Spatial Transcriptomics Platform Product Portfolio
  60. 8.10.5 M20 Genomics Recent Developments
  61. 8.11 Singleron Biotechnologies
  62. 8.11.1 Singleron Biotechnologies Company Information
  63. 8.11.2 Singleron Biotechnologies Business Overview
  64. 8.11.3 Singleron Biotechnologies Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Singleron Biotechnologies Spatial Transcriptomics Platform Product Portfolio
  66. 8.11.5 Singleron Biotechnologies Recent Developments
  67. 8.12 AtlasXomics
  68. 8.12.1 AtlasXomics Company Information
  69. 8.12.2 AtlasXomics Business Overview
  70. 8.12.3 AtlasXomics Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AtlasXomics Spatial Transcriptomics Platform Product Portfolio
  72. 8.12.5 AtlasXomics Recent Developments
  73. 8.13 10x Genomics
  74. 8.13.1 10x Genomics Company Information
  75. 8.13.2 10x Genomics Business Overview
  76. 8.13.3 10x Genomics Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 10x Genomics Spatial Transcriptomics Platform Product Portfolio
  78. 8.13.5 10x Genomics Recent Developments
  79. 8.14 Bruker
  80. 8.14.1 Bruker Company Information
  81. 8.14.2 Bruker Business Overview
  82. 8.14.3 Bruker Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bruker Spatial Transcriptomics Platform Product Portfolio
  84. 8.14.5 Bruker Recent Developments
  85. 8.15 Vizgen
  86. 8.15.1 Vizgen Company Information
  87. 8.15.2 Vizgen Business Overview
  88. 8.15.3 Vizgen Spatial Transcriptomics Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Vizgen Spatial Transcriptomics Platform Product Portfolio
  90. 8.15.5 Vizgen Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst